PCSK9 Inhibitor for Intracranial Atherosclerotic Symptomatic Stenosis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
An investigator-initiated, prospective, multicenter, randomized, double-blind, placebo-controlled trial comparing the 1-year incidence of stroke in patients with AIS or TIA within 7 days who are treated with either placebo or Recaticimab.
Epistemonikos ID: 9103e6c830021460fe787766841fb32a3ed57d90
First added on: Aug 14, 2025